Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A 26-Week Placebo-Controlled Efficacy and Safety Study of Mometasone Furoate/Formoterol Fumarate Combination Formulation Compared With Mometasone Furoate and Formoterol Monotherapy in Subjects With Persistent Asthma Previously Treated With Medium-Dose Inhaled Glucocorticosteroids

NCT00383240 is registered in ClinicalTrials.gov with Organon and Co as lead sponsor.

NCT NCT00383240
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00383240 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A 26-Week Placebo-Controlled Efficacy and Safety Study of Mometasone Furoate/Formoterol Fumarate Combination Formulation Compared With Mometasone Furoate and Formoterol Monotherapy in Subjects With Persistent Asthma Previously Treated With Medium-Dose Inhaled Glucocorticosteroids
Lead sponsor
Organon and Co
Phase
Phase 3
Overall status
Completed
Start date
September 30, 2006
Completion date
September 30, 2008
Enrollment
781 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

asthma